Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Optomed

3.65 EUR

+0.27 %

5,573 following

OPTOMED

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+0.27 %
-9.88 %
-2.67 %
-10.65 %
-21.67 %
-14.52 %
+9.12 %
-50.68 %
-20.31 %

Optomed operates in the medical technology sector. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that are resold under different brands. Operations are held on a global level, with the largest presence in the Nordic market. Customers consist of research institutes and hospitals. The company has its headquarters in Oulu.

Read more
Market cap
71.88M EUR
Turnover
123.77K EUR
P/E (adj.) (25e)
EV/EBIT (adj.) (25e)
P/B (25e)
EV/S (25e)
Dividend yield-% (25e)
Coverage
Recommendation
Buy
Target price
Updated
07.11.2025
Disclaimer
Juha Kinnunen
Juha Kinnunen

Analyst

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10.2.
2026

Annual report '25

6.5.
2026

Interim report Q1'26

8.5.
2026

General meeting '26

Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Press release11/7/2025, 7:48 AM

Redeye: Optomed Q3 (Review) - Solid growth with a positive devices segment development

Optomed
Regulatory press release11/6/2025, 7:00 AM

Optomed Oyj: Optomed Plc: Interim Report, January - September 2025

Optomed
Regulatory press release9/26/2025, 1:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Myllylä

Optomed

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release9/26/2025, 1:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Piila

Optomed
Regulatory press release9/26/2025, 1:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Himberg

Optomed
Regulatory press release9/26/2025, 1:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Knuutti

Optomed
Regulatory press release9/23/2025, 6:00 AM

Optomed Oyj: Optomed's Board has resolved upon a new option plan

Optomed
Regulation of medical devices and diagnostics in Europe
Analyst Comment9/19/2025, 5:18 AM by
Antti Siltanen

Regulation of medical devices and diagnostics in Europe

The EU is the world's second largest market for medical devices after the United States. In this article, we will go through the basics of EU regulation from an investor's perspective.

BioretecAiforia TechnologiesNexstimBiohitOptomedRevenio GroupModulightDetection TechnologyNightingale HealthBittium
Regulatory press release9/9/2025, 6:30 AM

Optomed Oyj: Composition of Optomed's Nomination Board

Optomed
Classification of medical devices and regulatory processes in the United States
Analyst Comment9/8/2025, 9:56 AM by
Antti Siltanen

Classification of medical devices and regulatory processes in the United States

We continue our series of articles focusing on Life Science investing, the first four parts of which focused on drug development. Subsequent articles will cover medical devices.

BioretecNexstimOptomedRevenio GroupModulightBittiumDetection Technology
Press release8/8/2025, 1:30 PM

Redeye: Optomed Q2 - Soft Q2 sales raises the stakes for H2 recovery

Optomed
Regulatory press release8/8/2025, 12:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Calarco

Optomed
Regulatory press release8/8/2025, 12:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Mäkinen

Optomed
Regulatory press release8/8/2025, 12:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Wen

Optomed
Regulatory press release8/8/2025, 12:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Tauriainen

Optomed
Regulatory press release8/8/2025, 12:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Lee

Optomed
Regulatory press release8/8/2025, 12:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Salonen

Optomed
Regulatory press release8/8/2025, 12:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Badlani

Optomed
Regulatory press release8/8/2025, 12:30 PM

Optomed Oyj: Change in Optomed's holding of treasury shares

Optomed
Regulatory press release8/7/2025, 6:30 AM

Optomed Oyj: Optomed's financial reporting in 2026

Optomed
Forum discussions
AEYE Health @linkedin: UCL’s research on the role of the LRG1 protein suggests that diabetes-induced retinal changes begin much earlier than previously thought. This elevates early screening to a whole new level. AI-based methods, such as AEYE-DS with portable cameras, can practically...
11 hours ago
by Mr. Stock
28
lyqbq.com 欧视博免散瞳眼底照相机Optomed Lumo®-朗逸医疗-临时起搏器|眼科设备网站 欧视博(Optomed)Lumo® 免散瞳眼底照相机是一款兼具手持与固定使用模式的多功能成像设备,适用于多种医疗场景的眼底检查需求。 Lumoa for the Chinese by a Shanghai dealer. The company is small, with about 50 employees, and its turnover is probably not very large. But of course, it could ...
yesterday
19
The Greek police, “Hellenic Police”, has acquired and trained to use Aurora. Cameras will certainly continue to be encountered in the occupational health care of larger companies/organizations. From companies where employees and their health are valued and cared for. linkedin.com...
12/2/2025, 7:03 PM
by TJ-Groupin Tuulipuku
19
One could sarcastically conclude from the course’s decline that the factory is already underwater
12/1/2025, 8:27 PM
by Mr. Stock
12
I didn’t find Lumon’s permit on the NMPA’s website, i.e., on the Chinese authorities’ website. If a permit has been obtained there, Optomed could have announced this. Apparently, that matter is also too small to be announced. Optomed Aurora has a permit. https://www.nmpa.gov.cn/datasearch...
yesterday
by Koukku
10
Well, what does that course matter anymore when according to that floodmap we are all already drowned here in Finland. And half of the Sahara is under water too.
12/1/2025, 9:02 PM
by Puutaheinää
10
In 2011, there was a stock exchange release about a flood, but this year no announcement has been made, so probably those factories are fine for now. https://investor.fabrinet.com/news-releases/news-release-details/fabrinet-reports-impact-due-tosevere-flooding-thailand Manufacturer...
12/1/2025, 8:58 PM
by Pohjolan Eka
9
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.